Denoci OP 60mg Injection
Prescription Required
Marketed By
cipla
Pack of
1 Prefilled Syringe(s)
Salt Composition
Denosumab
Storage
keep store in cold place
₹8299.69₹14062.50
40.98% Off
Inclusive of all taxes
1
Denoci OP 60mg Injection
Delivering To: —
Description
Denoci OP 60mg Injection is a doctor prescribed injection that used to treat osteoporosis in postmenopausal women and men at high fracture risk, as well as bone loss associated with hormone therapies for breast or prostate cancer, long-term glucocorticoid use, multiple myeloma, and bone metastases.Denoci OP 60mg Injection contains contains 60mg of Denosumab that improves overall bone health.
Indication
Osteoporosis
Dosage And Administration
Denoci OP 60mg Injection is administered subcutaneously (under the skin in the lower abdomen), depending on the cancer stage. Patients should not self-administer; it must be injected by a doctor or trained nurse. Consult a doctor for precise dosage and timing.
Mechanism Of Action
Denoci OP 60mg Injection contains 60mg of denosumab( a monoclonal antibody) works by binding to RANK ligand (RANKL), a protein essential for osteoclast formation, function, and survival.Denoci OP 60mg Injection reduces bone resorption, increases bone mineral density, and strengthens bone structure in osteoporosis or cancer-related to bone loss.
Faqs
Denoci OP 60mg Injection is mainly used to treat osteoporosis in postmenopausal women and men at high fracture risk, as well as bone loss associated with hormone therapies for breast or prostate cancer, long-term glucocorticoid use, multiple myeloma, and bone metastases.
Denoci OP 60mg Injection should be administered subcutaneously (under the skin) by a doctor or an experienced nurse. Patient should not self administer the injection.
If you miss a Denoci OP 60mg Injection dose, contact your doctor or healthcare provider immediately to reschedule; do not skip the dose, as they will determine the appropriate timing based on your treatment schedule and condition.
Yes, Serious side effects of Denoci OP 60mg Injection include osteonecrosis of the jaw, a typical femoral fractures, hypocalcemia (low calcium), and severe skin reactions. These side effects require immediate medical attention.
Denoci OP 60mg Injection is not safe for baby during pregnancy. Consult your doctor beforehand.
References
• Pageau, S. C. (2009, May). Denosumab. In MAbs (Vol. 1, No. 3, pp. 210-215). Taylor & Francis.
• Cummings, S. R., Martin, J. S., McClung, M. R., Siris, E. S., Eastell, R., Reid, I. R., ... & Christiansen, C. (2009). Denosumab for prevention of fractures in postmenopausal women with osteoporosis. New England Journal of Medicine, 361(8), 756-765.
• Hanley, D. A., Adachi, J. D., Bell, A., & Brown, V. (2012). Denosumab: mechanism of action and clinical outcomes. International journal of clinical practice, 66(12), 1139-1146.
• Sheedy, K. C., Camara, M. I., & Camacho, P. M. (2015). Comparison of the efficacy, adverse effects, and cost of zoledronic acid and denosumab in the treatment of osteoporosis. Endocrine Practice, 21(3), 275-279.
Related Products
MARKETER DETAILS
cipla
DISCLAIMER
The contents of this website are for informative purposes only. They are not deliberated to be an alternative to any professional medical prescription and treatment. Seek the advice of a qualified health provider for questions regarding the medical condition. Do not ignore any professional medical advice because of something you have read on this website. This website offers links to other websites, thereby enabling you to go to the other website directly. Therefore, Magicine Pharma isn't responsible for the content of the links in the website or links in the linked websites. The links are provided to assist the visitors and are not approved by any professional health provider.